University College, London: clinical-trial pipeline

University College, London is the sponsor of 649 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 157 are not yet finished and 5 were first posted in the last 90 days. Source: Arcadium Data, data as of .

Open trials157
Phase 2/3 and 362
Countries50
New in 90 days5

Trials by phase

PhaseTrials
Not applicable432
Phase 287
Phase 350
Phase 130
Phase 1/225
Phase 2/312
Phase 48
Early phase 14
Not stated1

Trials by status

StatusTrials
Completed255
Unknown200
Recruiting72
Not yet recruiting44
Active, not recruiting41
Terminated20
Withdrawn or not authorised14
Suspended or halted3

Condition areas

AreaTrials
Oncology202
Neurology107
Cardiovascular98
Nephrology and urology67
Infectious disease and vaccines54
Rare and genetic diseases36
Respiratory32
Psychiatry and mental health31
Gastroenterology and liver29
Women's health and obstetrics26
Immunology and rheumatology22
Metabolic and endocrine (diabetes, obesity)22

Countries

CountryTrials
United Kingdom546
Germany11
Spain10
Italy9
United States9
Australia8
France8
Ireland8
Netherlands8
Canada7
Portugal7
Brazil5
Denmark5
India5
Uganda5

Latest changes

DayChangeTrial
2026-09-21New trial postedRefining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO) -…
2026-09-11New trial postedDancing as an Alternative to the Traditional Exercising in Older Adults With Cardiac Dise…
2026-09-10New trial postedPRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Ver…
2026-09-09New trial postedAdvanced Diffusion Magnetic reSonance Prostate Imaging for Reducing Extraneous Biopsies (…
2026-08-28New trial postedAn Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in Children and Ado…

Open trials

The 25 most recently changed open trials.

Registry idTitlePhaseStatusCountries
NCT02804815Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therap…Phase 3Active, not recruitingUnited Kingdom, Ireland
NCT03288532Renal Adjuvant MultiPle Arm Randomised TrialPhase 3RecruitingSpain, France, United Kingdom
NCT06320067A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate CancerPhase 3Not yet recruitingGermany, Spain, United Kingdom, Ireland
NCT07717632AI-enhanced LF-MRI in EpilepsyNot applicableActive, not recruitingUnited Kingdom
NCT05990751Multi-modular Chimeric Antigen Receptor Targeting GD2 in NeuroblastomaPhase 1Active, not recruitingUnited Kingdom
NCT04340245Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progr…Not applicableActive, not recruitingUnited Kingdom
NCT07079787Telerehabilitation Decision Support System: Pilot Testing ProtocolNot applicableNot yet recruitingGermany, United Kingdom, Greece, Portugal +1
NCT06626555Clinical Trial to Evaluate the Effects of Letermovir Prophylaxis on T-cell Immune Activation in Participants…Phase 2Not yet recruiting
NCT07115927pReOperative Dostarlimab and Novel Therapies in EndOmetrial CancerPhase 2Not yet recruiting
NCT06534580Virtual Reality for Advanced Cancer PainNot applicableActive, not recruitingUnited Kingdom
NCT07414940ACTinium in Castrate-RESistant Prostate Cancer After LUTEtiumPhase 1/2RecruitingUnited Kingdom
NCT06505798Cryoballoon/Radiofrequency/Pulsed Field Ablation of Atrial Fibrillation Versus Medical Treatment for HeartNot applicableRecruitingCanada, United Kingdom
NCT05185739Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)Phase 2RecruitingUnited Kingdom
NCT03813836Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCCPhase 2Active, not recruitingUnited Kingdom
NCT07506330The SENSE Study: Surgical ENvironment Stress EvaluationNot applicableRecruitingUnited Kingdom
NCT06778083STI Prophylaxis and Emergence of Antimicrobial ResistanceNot applicableRecruitingUnited Kingdom
NCT01194648Focal Therapy for Prostate Cancer Using HIFUNot applicableRecruitingUnited Kingdom
NCT04067713Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate CancerNot applicableActive, not recruitingUnited Kingdom
NCT07163143Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Throug…Phase 3Not yet recruitingPakistan, South Africa, Zimbabwe
NCT03880097Enabling the Study of Metabolism in Breast Cancer Through Collection of Fresh-tissue BiopsiesNot applicableNot yet recruiting
NCT07650539Respiratory OBservation Using Ultra-Sensitive nanoTechnologyNot applicableNot yet recruitingUnited Kingdom
NCT07024836PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice ExperimentNot applicableRecruitingUnited Kingdom
NCT06793631Mapping Financial Support for the Terminally IllNot applicableNot yet recruitingUnited Kingdom
NCT04602429Children's Acute Surgical Abdomen ProgrammeNot applicableActive, not recruitingUnited Kingdom
NCT06801925Evaluating the Effectiveness and Acceptability of a GPT-4o and RAG-Based Voice Chatbot for Depression Screeni…Not applicableRecruitingUnited Kingdom

All sponsors: clinical-trial pipeline by sponsor.

Track a sponsor's pipeline

The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.

Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.

Cite as: Arcadium Data, "University College, London clinical trials: 157 open, 62 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/university-college-london/, data as of 2026-10-25.